drugset / Trial / NCT05901454

Yellow Fever Human Infection Model With YF-17D

NCT05901454

NaSingle-groupOpen-labelOther

Summary

No antiviral treatment exists for yellow fever, only supportive care, and therefore we rely on prevention through vaccination. Although this vaccine is very effective, stockpiles are insufficient in outbreak situations and some people have a contraindication to be vaccinated. For those who are unprotected and at risk of yellow fever infection, treatment could be life saving.

Timeline

Start
2023-02-17
Primary completion
2023-07-01
Completion
2024-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Yellow Fever Vaccine Vaccine 0.5 ml Subcutaneous

Indications